MedPath
NMPA Approval

Regadenoson Injection

国药准字H20244139

June 25, 2024

Drug Information

瑞加诺生注射液

注射剂

5ml:0.4mg(按C₁₅H₁₈N₈O₅计)

化学药品

June 25, 2024

Company Information

Applicant Company

南京高新开发区MA010-1号地

Manufacturing Company

南京高新技术产业开发区学府路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞加诺生注射液 - NMPA 批准文号 | MedPath